Prevalence of Abnormal Levels of Serum Tumour Markers in Elderly People
Authors:
Open Access
- 1 January 1996
- journal article
- research article
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 25 (1) , 45-50
Abstract
The study was conducted to evaluate the prevalence of abnormal levels of several serum tumour markers in an institutionalized elderly population. Serum tumour markers assay of carcinoembryonic antigen (CEA), the carbohydrate antigens CA 19-9, Ca 72-4 and CA 15-3 (Enzymun-test, Boehringer Mannheim GmbH Diagnostic), alpha-fetoprotein (AFP) and prostate specific antigen (PSA) (Abbot Diagnostic Division) were performed in 228 unselected, institutionalized elderly subjects, whose mean age (SD) was 82.4 (5.79) range (66–99 years). Patients with acute or neoplastic diseases were excluded from the study. The serum markers were also measured in 52 healthy young adults (controls). Using the established threshold values, 92 subjects (40%) were found to have at least one elevated marker. PSA was elevated in 33%, CA 19-9 in 16%, CEA in 11.5%, CA 15-3 in 11%, CA 72-4 in 8% and AFP in 3%. We found a significant difference in the serum levels between the two groups for CEA, CA 19-9. CA 15-3, and PSA (p < 0.001). Healthy aged people appear to have an elevated prevalence of elevated levels of serum tumour markers. The results suggest that apart from PSA, elevated antigen levels in elderly subjects are related to the ageing process itself rather than to occult pathology.Keywords
This publication has 26 references indexed in Scilit:
- Screening for Prostatic Carcinoma with Prostate Specific AntigenJournal of Urology, 1992
- The Distribution of Prostate Specific Antigen in Men Without Clinical or Pathological Evidence of Prostate Cancer: Relationship to Gland Volume and AgeJournal of Urology, 1992
- Gerontology as oncology. Research on aging as the key to the understanding of cancerCancer, 1991
- Prevention and detection in older personsCancer, 1991
- Cancer in the elderly: why so badly treated?The Lancet, 1990
- Clinical use of Prostate Specific Antigen in Patients with Prostate CancerJournal of Urology, 1989
- Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 72) on a novel pancarcinoma antigen (TAG‐72)International Journal of Cancer, 1986
- Cumulative effects of age and pathology on plasma carcinoembryonic antigen in an unselected elderly populationEuropean Journal of Cancer and Clinical Oncology, 1984
- Alphafetoprotein levels of liver cancer patients and controls in a European populationCancer, 1980
- Proliferative homeostasis and its age-related aberrationsMechanisms of Ageing and Development, 1979